Podcast appearances and mentions of jonathan garner

In this episode of Market Minutes, Nandita Khemka talks about the key factors to watch out for today before the domestic market opens. The BSE Sensex and Nifty 50 saw a record closing high on weekly expiry day. What are the key levels to watch out for on the Nifty 50 and Nifty Bank indices? Can the Nifty 50 finally cross the 23,500 hurdle as we head into the long weekend? Ambuja Cements, Vodafone Idea and Suzlon will be among the stocks to watch out for today. Also, catch Jonathan Garner of Morgan Stanley in the Voice of the Day segment. Market Minutes is a morning podcast that puts the spotlight on hot stocks, key data points, and developing trends.

Our Chief Asia and Emerging Market Equity Strategist reviews an up-and-down first quarter for markets across the region, and gives an update on which sectors investors should be eyeing. ----- Transcript -----Welcome to the Thoughts on the Market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Market Equity Strategist. Along with my colleagues bringing you a variety of perspectives, today I'll be talking about our key investment views in Asia. It's Tuesday, Mar 19th at 9 am in Singapore.It's been quite a first quarter in Asian equities with a wide degree of dispersion in market returns. At one end of the spectrum Japan's Nikkei index is up 16 percent. At the other end, despite a recent rally, the Hang Seng index in Hong Kong is down 2 percent for the year. Meanwhile, the AI thematic has helped Taiwan into second place regionally, with a 10 percent gain; but Korea has risen by a lot less.Our highest conviction views remains that we're in the midst of multi-year secular bull markets in Japan and India, whilst at the same time China is in a secular bear market. So, let's lay out the building blocks of those theses.Firstly, Japan's Return on Equity Journey. We think that markets – like stocks – reward improvement in profitability or ROE. The drivers of the ROE improvement are numerous but include domestic reflation, a weaker Yen, a productive capex cycle and improved capital management by Japan's leading firms. And these together have led to improving net income margins in two-thirds of industries versus a decade ago. We forecast robust EPS growth of around 9 percent in 2024, with similar growth in 2025. Now that's assuming our foreign exchange strategists' USD/JPY forecast of 140 for the fourth quarter of this year is accurate. This week the BOJ – the Bank of Japan – is considering whether to exit its Negative Interest Rate Policy and abolish or flex yield curve control. If it does so, that will be a sign – along with recent strong wage gains – that Japan has definitively exited deflation.Secondly, India's Decade. Multipolar world trends are supporting foreign direct investment (FDI) flows and portfolio flows to India, whilst positive demographics from a rapidly growing working age population are also supporting the equity market. India is holding national elections in May, and we will be watching the policy framework thereafter. But our base case is little change; success that India has achieved in macro-stability is underpinning a strong capex and profits outlook.Finally, China's Deflationary Challenge. China continues to battle what we've termed its 3D challenge of Debt (now standing at 300 per cent of GDP), Demographics and Deflation. And profitability has fallen steadily in recent years – so going in the opposite direction from Japan; approximately halving since the middle of the last decade, whilst earnings have missed for nine straight quarters. We think more forceful countercyclical measures are needed to boost demand in China given incipient balance sheet recession due to headwinds from property and local government austerity.Finally, to summarize some of our sector and style views. We still like Korea and Taiwan's semiconductors, into an expected 2024 recovery in traditional product areas such as smart phone, as well as the new theme of AI related demand. We are positive on Financials in India, Indonesia and Singapore; Industrials in India and Mexico; and Consumer Discretionary in India. On the quant and style side, we're neutral on value versus growth as we expect the path to lower yields to be bumpy – as inflation risk remains. And we have recently recommended investors to reduce momentum exposure for risk management purposes given the strong outperformance year to date.Thanks for listening. Subscribe to Thoughts on the Market on Apple Podcasts or wherever you listen – and leave us a review. We'd love to hear from you.

Jonathan Garner @the_meddlingmushroom , a Navy Veteran, mycologist, and entrepreneur, shares his expertise in clean rooms and lab processes. He discusses his journey in mycology and the transition from pharmaceuticals to medicinal mushrooms. Jonathan emphasizes the importance of sharing knowledge and expertise in the mycology community. He also talks about the challenges in the mushroom market and the shift towards gourmet and functional mushrooms. Jonathan finds balance and self-care through outdoor activities and cultivating fruits and vegetables. He shares his favorite mushroom varieties and phenotypes. In this conversation, Jonathan discusses various topics related to mushrooms, including different varieties, growing experiences, and the utilization of mushrooms for health benefits. He also shares his thoughts on microdosing and the future of the mushroom market. Jonathan emphasizes the importance of maintaining stability and growth, both in mind and body, and highlights the significance of community support. https://www.instagram.com/the_meddlingmushroom/ https://www.instagram.com/fungi_alternatives/ https://fungi-alternatives.com/ Please leave us a 5 star review :D • Want to learn how to grow your own mushrooms? Join my community on Patreon and Discord • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.Patreon.com/Mycotrophic⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Follow me on Instagram • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/mycotrophic⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Subscribe to my Youtube Channel • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.Youtube.com/mycotrophic⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Myco Alchemy - Mycology Grow Supplies @Mycoalchemy_ • Sterilized Grain, Bio Dynamic Substrate, Pre Poured Agar, and more! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://myco-alchemy.com/?ref=3058t1smm1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Lab Rat Flow Hoodz @LRFHOODZ • Custom Hand Made Flow Hoods with FREE shipping in the USA! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.labrathoodz.com/?ref=WEKs9qy7⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Inoculate the World - Quality Mushroom Shp0res & Cultures • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://inoculatetheworld.com/?ref=9⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Microppose : Adherable injection ports and lid filters, tub filter discs, mono-tubs, and more! • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://microppose.com/r?id=ii9tqs⁠⁠⁠⁠

Original Release on December 7th, 2023: Will India equities continue to outperform China equities in 2024? The two key factors investors should track.----- Transcript -----Welcome to Thoughts on the market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Market Equity Strategist. Along with my colleagues, bringing you a variety of perspectives, today I'm going to be discussing our continued preference for Indian equities versus China equities. It's Thursday, December 7th at 9 a.m. in Singapore. MSCI India is tracking towards a third straight year of outperformance of MSCI China, and India is currently our number one pick. Indeed, we're running our largest overweight at 100 basis points versus benchmark. In contrast, we reduced China back to equal weight in the summer of this year. So going into 2024, we're currently anticipating a fourth straight year of India outperformance versus China. Central to our bullish view on India versus China, is the trend in earnings. Starting in early 2021, MSCI India earnings per share in US dollar terms has grown by 61% versus a decline of 18% for MSCI China. As a result, Indian earnings have powered ahead on a relative basis, and this is the best period for India earnings relative to China in the modern history of the two equity markets. There are two fundamental factors underpinning this trend in India's favor, both of which we expect to continue to be present in 2024. The first is India's relative economic growth, particularly in nominal GDP terms. Our economists have written frequently in recent months on China's persistent 3D challenges, that is its battle with debt, deflation and demographics. And they're forecasting another subdued year of around 5% nominal GDP growth in 2024. In contrast, their thesis on India's decade suggests nominal GDP growth will be well into double digits as both aggregate demand and crucially supply move ahead on multiple fronts. The second factor is currency stability. Our FX team anticipate that for India, prudent macro management, particularly on the fiscal deficit, geopolitical dynamics and inward multinational investment, can lead to continued Rupee stability in real effective terms versus volatility in previous cycles. For the Chinese Yuan, in contrast, the real effective exchange rates has begun to slide lower as foreign direct investment flows have turned negative for the first time and domestic capital flight begins to pick up. Push backs we get on continuing to prefer India to China in 2024, are firstly around potential volatility of the Indian markets in an election year. But secondly, a bigger concern is relative valuations. Now, as always, we feel it's important to contextualize valuations versus return on equity and return on equity trajectory. Currently, India is trading a little over 3.7x price to book for around 15% ROE. This means it has one of the highest ROE's in emerging markets, but is the most expensive market. And in price to book terms, second only to the US globally. China is trading on a much lower price to book of 1.3x, but its ROE is 10% and indeed on an ROE adjusted basis, it's not particularly cheap versus other emerging markets such as Korea or South Africa. Importantly for India, we expect ROE to remain high as earnings compound going forward, and corporate leverage can build from current levels as nominal and real interest rates remain low to history. So the outlook is positive. But for China, the outlook is very different. And in a recent detailed piece, drawing on sector inputs from our bottom up colleagues, we concluded that whilst the base case would be for ROE stabilization, if reflation is successful, there's also a bear case for ROE to fall further to around 7% over the medium term, or less than half that of India today. Finally, within the two markets we're overweight India, financials, consumer discretionary and industrials. And these are sectors which typically do best in a strong underlying growth environment. They're the same sectors on which we're cautious in China. There our focus is on A-shares rather than large cap index names, and we like niche technology, hardware and clean energy plays which benefit from China's policy objectives. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Will India equities continue to outperform China equities in 2024? The two key factors investors should track.----- Transcript -----Welcome to Thoughts on the market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Market Equity Strategist. Along with my colleagues, bringing you a variety of perspectives, today I'm going to be discussing our continued preference for Indian equities versus China equities. It's Thursday, December 7th at 9 a.m. in Singapore. MSCI India is tracking towards a third straight year of outperformance of MSCI China, and India is currently our number one pick. Indeed, we're running our largest overweight at 100 basis points versus benchmark. In contrast, we reduced China back to equal weight in the summer of this year. So going into 2024, we're currently anticipating a fourth straight year of India outperformance versus China. Central to our bullish view on India versus China, is the trend in earnings. Starting in early 2021, MSCI India earnings per share in US dollar terms has grown by 61% versus a decline of 18% for MSCI China. As a result, Indian earnings have powered ahead on a relative basis, and this is the best period for India earnings relative to China in the modern history of the two equity markets. There are two fundamental factors underpinning this trend in India's favor, both of which we expect to continue to be present in 2024. The first is India's relative economic growth, particularly in nominal GDP terms. Our economists have written frequently in recent months on China's persistent 3D challenges, that is its battle with debt, deflation and demographics. And they're forecasting another subdued year of around 5% nominal GDP growth in 2024. In contrast, their thesis on India's decade suggests nominal GDP growth will be well into double digits as both aggregate demand and crucially supply move ahead on multiple fronts. The second factor is currency stability. Our FX team anticipate that for India, prudent macro management, particularly on the fiscal deficit, geopolitical dynamics and inward multinational investment, can lead to continued Rupee stability in real effective terms versus volatility in previous cycles. For the Chinese Yuan, in contrast, the real effective exchange rates has begun to slide lower as foreign direct investment flows have turned negative for the first time and domestic capital flight begins to pick up. Push backs we get on continuing to prefer India to China in 2024, are firstly around potential volatility of the Indian markets in an election year. But secondly, a bigger concern is relative valuations. Now, as always, we feel it's important to contextualize valuations versus return on equity and return on equity trajectory. Currently, India is trading a little over 3.7x price to book for around 15% ROE. This means it has one of the highest ROE's in emerging markets, but is the most expensive market. And in price to book terms, second only to the US globally. China is trading on a much lower price to book of 1.3x, but its ROE is 10% and indeed on an ROE adjusted basis, it's not particularly cheap versus other emerging markets such as Korea or South Africa. Importantly for India, we expect ROE to remain high as earnings compound going forward, and corporate leverage can build from current levels as nominal and real interest rates remain low to history. So the outlook is positive. But for China, the outlook is very different. And in a recent detailed piece, drawing on sector inputs from our bottom up colleagues, we concluded that whilst the base case would be for ROE stabilization, if reflation is successful, there's also a bear case for ROE to fall further to around 7% over the medium term, or less than half that of India today. Finally, within the two markets we're overweight India, financials, consumer discretionary and industrials. And these are sectors which typically do best in a strong underlying growth environment. They're the same sectors on which we're cautious in China. There our focus is on A-shares rather than large cap index names, and we like niche technology, hardware and clean energy plays which benefit from China's policy objectives. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

With volatility in Asia and emerging markets causing both upswings and downswings, certain markets will be critical as uncertainty continues.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Market Equity Strategist. Along with my colleagues, bringing you a variety of perspectives, today I'll be discussing why we turned more cautious on our coverage recently. It's Thursday, September the 28th at 9 a.m. in Singapore. We turned more cautious on our coverage in early August, downgrading Taiwan and China to equal weight and Australia to underweight, whilst raising India, which we view as defensive, to a major overweight. For India, multi-polar world trends are supporting a surge in inward foreign direct investment in manufacturing, and portfolio flows into both bonds and equities. The country's reforms and macro stability agenda, particularly in fiscal policy, is underpinning a strong capital expenditure and profits outlook. We also maintain Japan equities, currency hedged, as our top pick in global equity markets. Japan has strong nominal GDP growth, positive earnings per share revisions and valuations which remain reasonable in our view, at a little over 14x forward price to earnings. However, the continued debate on China's growth slowdown and now a sudden further rise in US real yields are, in our view, likely to pressure markets lower generally, in what is seasonally a difficult period for our asset class. Volatility is now and generally has been a feature of Asia and emerging equity markets. Hence the intense interest in market timing and hedging strategies in an asset class which has, with the recent exception of Japan, failed to deliver attractive, sustained compound returns for the US-dollar-based investor. Indeed, we've made the point before that on a risk adjusted basis, Asia and emerging equity markets are what is known as Sharpe ratio inefficient in a multi asset sense, that is returns have not compensated for volatility compared to other benchmarks.All of our coverage markets have higher volatility than the S&P 500, and in many cases significantly so. In particular, China A shares, the Hang Seng China Enterprise Index and until recently, the India benchmark Sensex. In terms of why this is the case it probably has to do with the following characteristics. Firstly, more volatility in earnings cycles. Secondly, less developed domestic institutional investor bases than in many developed markets. And thirdly, greater reliance on foreign flows, which are inherently less sticky than domestic flows. However, this is changing now for the India market. Combining data allows us to develop a simple scoring framework to assess complacency versus fear in relation to drawdown risk. It suggests a somewhat complacent mode in general, but particularly for China A, Australian equities, that's the ASX 200, and the overall MSCI EM benchmark, much less so for Topix, Nikkei and the Hang Seng Index. And this reinforces our view that Japan equities are a key holding to maintain currently. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts, and share Thoughts on the Market with a friend or colleague today.

Jonathan Garner works for the National Weather Service as a Meteorologist. Be sure to check out his blog (https://tornadocyclone.blogspot.com/) to keep up with his mountain adventures!

With the rupee appreciating, manufacturing and services in a consistent rally and demographic trends on an upswing, India may be better poised for a long-term boom than other markets in Asia.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, today I'll be talking about why India is now our preferred market in Asian equities. It's Tuesday, August 15th at 8am in Singapore. Before we dive into the details of some important changes in view that we've recently published, let's take a step back and set the scene for today's changes in a broader thematic context. Firstly, a reminder that we think we began a new bull market in Asia and EM last October. And from the trough in late October, the MSCI Emerging Markets Index is up around 25%. So the changes we're making are about identifying leadership at the market level as we transition towards a midcycle environment. Secondly, we continue to prefer Japan within our coverage, which remains Morgan Stanley's top pick in global equities but is a developed market. In terms of the changes that we've made on the downgrades side, for Taiwan, it has led the way off the bottom, rising almost 40% since last October. It's a market dominated by technology and export earnings, where the structural trend in return on equity has been positive in recent years as those firms have succeeded globally. Our upgrade last October was a simple cyclical story of distressed valuations at a time of depressed sentiment about underlying demand trends in semiconductors. The situation is very different today. Valuations are back to mid-cycle levels, and while demand remains weak in key areas such as smartphones and conventional cloud, a path to recovery is becoming more evident. Moreover, as has been the case in many prior cycles, a new end use category AI service is generating significant excitement. Our China downgrade, which is linked to our Australia downgrade via the Australian mining stocks, has a different structural set up. The China market, unlike Taiwan, is overwhelmingly dominated by domestic demand stocks and its domestic demand which has failed to recover convincingly in the post-COVID environment. Indeed, the current investor debate is centered on whether China's demographic transition, high domestic debt to GDP ratio and over-investment in property and infrastructure are starting to generate a balance sheet recession. Core inflation is stuck close to zero, with evidence of high unemployment in the young population and weak wages, with households and private firms no longer willing to lever up. Now, recent statements from the Politburo have begun to acknowledge the need to reverse some of the measures that have pressured the property market. But there is no easy way out of the intertwined property and local government financing debt burdens that have built up in the years when the growth model did not transition fast enough. And at the same time, China faces the new challenge of coping with multi-polar world pressures from the US in particular, which is generating new restrictions on inward technology transfers. All that said, we do not rule out moving back to a more positive stance on China, should policy implementation be more aggressive than hitherto. For India, the situation is in stark contrast to that in China, as was borne out to me by a recent visit in June to the Morgan Stanley annual Investment Summit in Mumbai. With GDP per capita, only $2,500 versus $13,000 for China and positive demographic trends, India is arguably at the start of a long wave boom at the same time as China may be ending one. Manufacturing and services PMIs have rallied consistently since the end of COVID restrictions, in contrast to the rapid fade seen in China. Also, real estate transaction volumes in construction have broken out to the upside. Moreover, India's ability to leverage multi-polar world dynamics is a significant advantage. Simply put, India's future looks to a significant extent like China's past, and in this context, it's particularly relevant to note long run trends in exchange rates now show the Indian rupee more stable and actually appreciating whilst the renminbi is depreciating. So considering Indian equities and Chinese equities as a pair in dollar terms, we appear to be at the beginning of a new era of Indian outperformance compared to China. From early 2021, India has broken out dramatically to the upside in performance. And whilst reversion to the mean is often a powerful force in finance, we think this represents a structural break in India's favor. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

While Japan's equities have continued to rally, a roster of sector leading companies and a weak Yen could signal this bullish story is only just beginning.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley. Along with my colleagues bringing you a variety of perspectives, I'll be sharing why Japan Equities could be a key part of the bullish story in Asia this year. It's Thursday, May the 25th at 10 a.m. in New York. Japan equities have rallied substantially during the current earnings season and we think further gains are increasingly likely. The theme of return on equity improvement, driven by productive CapEx and better balance sheet management, is clearly finding traction with a wide group of international investors. We first introduced this theme in our 2018 Blue Paper on Japan, where we described a journey from laggard to leader, which we felt was starting to take place due to a confluence of structural reforms such as the Corporate Governance Code and Institutional Investor Stewardship Code, as well as changes in company board composition and outside activist investor pressure. Japan has a formidable roster of world class firms, which we have identified as productivity and innovation leaders in areas such as semiconductor equipment, optical, healthcare, medtech, robotics and traditional heavy industrial automotive, agricultural and commodities trading, specialty chemicals. As well as more recent additions in Internet and E-commerce, many of which sell products far beyond Japan's borders. For the market overall, listed equities ROE has more than doubled in the last ten years, and it's now set to approach our medium term target of 11 to 12% by 2025. Company buybacks are analyzing at a record pace and total shareholder return, that is the sum of dividends and buybacks, is running at 3.6% of market capitalization. Yet Japan equities are still trading on only around 13 times forward price to earnings. And Japanese firms have a low cost of capital, given the country's status as a high income sovereign, with membership of the G7, as highlighted by Premier Kishida hosting its recent summit in his home town of Hiroshima. An additional near-term catalyst for Japan equities is that the yen is tracking significantly weaker year to date at around 135 to the U.S. dollar than company modeling, which was for around 125. Given the export earnings skew of the market, this is a positive.All in all, Japan equities are set, we think, to more than hold their own versus global peers and be a key part of a bullish story in Asian equities this year. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

In this episode, Rachael speaks with the founder of Mind Over Tech, Jonathan Garner, a seasoned web developer and UX designer. They discuss intentional tech use and how companies manipulate algorithms to grab your attention. They explore the negative impact of social media on people's lives, particularly young adults, and how to mitigate these effects. Jonathan shares his personal experience with technology and why he created the Digital Habit Lab, a deck of cards designed to help individuals improve their wellbeing, productivity, and creativity in the digital space. If you're looking for practical tips to develop healthier relationships with your phone, this episode can't be missed!   ABOUT THE SHOW: Things I Wish I'd Known is a podcast that aims to create positive change in your life through conversation, with new episodes released every Wednesday. Host Rachael shares her knowledge, emotions, and laughs, covering everything from mental health, suicide, and spirituality to makeup and skincare. With each episode, Rachael and her guests offer practical advice to help you master your mental health and fall back in love with yourself. Join the conversation by tagging @ on Instagram and Facebook. For more information on Rachael, visit her website. Listen and follow on Spotify or Apple Podcasts, or visit https://thingsiwishidknown.co.uk  for all links. WORK WITH RACHAEL:  Corporate wellbeing training on stress and burnout  1:1 EFT Therapy work  Join Happy Habits Club   ABOUT JONATHAN: https://www.mindovertech.com/ Get the digital habit lab cards https://shop.mindovertech.com/products/digital-habit-lab/?utm_source=tiwik_podcast USEFUL LINKS: If you're struggling with mental health, reach out to these amazing charities for help: addaction: https://www.addaction.org.uk/ Alcoholics Anonymous: https://www.alcoholics-anonymous.org.uk/ Samaritans: Call for free on 116 123, or visit https://www.samaritans.org/ Anxiety UK: https://www.anxietyuk.org.uk  

After a correction that took place in recent months, Asia and emerging markets are once again rallying. But how have these regions sustained their ongoing bull markets?----- Transcript ----- Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, today I'll be talking about the recent correction and ongoing bull market in Asia and emerging market equities. It's Thursday, April 13th, at 10 a.m. in London. Asia and emerging market equities underwent a six week correction in February and March, in what we think is an ongoing bull market. However, they've recently stabilized and begun to rally once more as we head into the new quarter. Importantly, the catalyst for the correction came from outside the asset class in the form of banking sector risks in both the U.S. and Europe. EM assets suffered some limited challenges, for example, at one point major EM currencies gave up most of that year to date gains against the U.S. dollar. However, as investors appraised the situation, they recognized that little had actually changed in the investment thesis for the EM asset class this year. At the core of this thesis is the ongoing recovery in China. After an initial surge in mobility indicators and services spending, there is now a broadening out of the recovery to include manufacturing production and even recent strength in property sales. Like the rest of Asia and EM these days, Chinese growth is self-funded in the main from domestic banking systems which are generally well capitalized and liquid. Indeed, just as question marks are now appearing over bank credit growth prospects in the U.S. in segments like commercial real estate lending, the opposite is taking place in China as the authorities encourage more bank lending. Elsewhere, we're also seeing an encouraging set of developments in the semiconductors and technology hardware cycles, which matter for the Korea and Taiwan markets. Although end use demand in most segments remained very weak in the first quarter, we believe our thesis that we are passing through the worst phase of the cycle was confirmed by positive stock price reactions to news of production cuts by industry leaders. We think stock prices in these sectors troughed last October, as usual about six months ahead of the weakest point of industry fundamentals and the industry now has a lower production base to begin to recover from the second half of the year onwards. Elsewhere in EM, we recently adopted a more positive stance on the Indian market after being cautious for six months. Valuations adjusted meaningfully lower in that timeframe and we think Indian equities are now poised to join in the rally from here on an improving economic cycle outlook, as well as heightened structural interest in the market by overseas investors. India continues to benefit from ongoing positive household formation, industrialization and urbanization themes which are well represented in domestic equity benchmarks. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

Sunday Evening Worship - with Jonathan Garner

Sunday Evening Worship Lesson by Jonathan Garner

Emerging markets are turning bullish and China's reopening leaves room for an increase in consumption. What sectors and industries might benefit from this upturn?----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and emerging market equity strategist at Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, in this episode I'll explain why the bull market in emerging market equities is still young. It's Thursday, 2nd of February at 8 a.m. in Singapore. In our view, the bull market in emerging market equities is still young. We entered a bull market, conventionally defined as up 20% from the trough, in the second week of January, having completed the bear market in mid-October. And bull markets typically last at least a year in our asset class, although the pace of recent market gains will probably slow. Unlike the U.S. market, earnings estimates revisions in Asia and emerging markets are now inflecting upwards, and that's why emerging equities are performing U.S. equities more rapidly even than in early 2009. And we think this outperformance is likely to continue a while longer. As we've entered a bull market the 52 week rolling beta, or measure of correlation of emerging markets versus U.S. equities, has undergone a regime shift falling from around 0.8 times in the third quarter last year to just 0.4 times currently. And even more striking, the beta of the Hang Seng index, at the leading edge of the current bull market in our asset class, compared to the S&P 500 has fallen close to zero. This is lower than at any point in the last 30 years of data and speaks to an environment of extreme decoupling and performance. These factors have led us to raise our growth stock exposure in recent months. Particularly in North Asia ex-Japan, so that's China, Korea and Taiwan, we expect those markets to continue to outperform, as is typical in the early phases of a bull market, whilst we expect Southeast Asian markets, ASEAN and India, which were defensive outperformers during the bear market to underperform as the bull market gets going. On the sector side, we're overweight semiconductors and technology hardware and think that the fourth quarter of 2022 was the trough for industry fundamentals, with recovery expected in the second half of this year as inventory reduces and demand recovers, particularly in China. Whilst we praised our emerging markets and China targets several times in recent months, we recently cut our Japan target for TOPIX given the headwind of yen strength. And we prefer Japan banks to the overall market as they're one of the few sectors that's positively leveraged to a stronger yen. Finally, we'd like to emphasize that China reopening is probably going to be more V-shaped than the consensus expects, with substantial excess savings in consumer pockets likely to support consumption through this year. Now, this factor is prima facie more bullish the energy sector, which we're also overweight, than the broad materials sector, which is more leveraged to property demand in China, which we think will be slower to recover. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

One of the frequent questions regarding Emerging Markets is whether outperformance will hold for the short term or the long term. So what factors should investors consider when evaluating the cross asset performance of EM?----- Transcript -----Welcome to Thoughts on the Market. I'm Andrew Sheets, Chief Cross-Asset Strategist for Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about trends across the global investment landscape and how we put those ideas together. It's Friday, January 13th at 2 p.m. in London. A common question when talking about almost any market is whether the view holds for the short term or the long term. Call it a question of whether to "rent" versus "own". Is this a strategy that could work over the next six months or is it geared to the next six years? This question comes up most frequently when we discuss emerging market or EM assets. We like EM on a cross-asset basis. We think equities in EM outperform those in the U.S. We think EM currencies outperform the U.S. dollar and the British pound. And we think EM sovereign bonds perform well on an outright basis and also relative to U.S. high yield. Several factors underlie this positive view. First, as we've discussed in this program before, a number of key themes for 2023 look like the mirror image of 2022. Last year saw U.S. growth outperform China, inflation rise sharply and central banks hike aggressively, a combination that was pretty tough in emerging market assets. But this year we see growth in China accelerating while the U.S. slows, inflation falling and central banks pausing, a reversal that would seem much better for EM. And this is all happening at a time when EM assets still enjoy a valuation advantage. Emerging market equities, currencies and sovereign bonds all still trade at larger than average discounts to their U.S. peers. All of that supports the near-term case for outperformance in emerging markets, in our view. But what about the longer term story? Here we admit there are still some uncertainties. On one hand, there are some countries where there's a quite positive long run outlook in the eyes of my research colleagues. I'd highlight Mexico here, a country that we think could be a major long term beneficiary of U.S. companies looking to shorten supply chains and bring more production back from Asia. But there are also major long term uncertainties, especially related to earnings power. The case for EM equities is often based around the idea that you get the higher growth of the developing world at lower valuations, an attractive combination that offsets the higher political and economic volatility. But as my colleague Jonathan Garner, Head of Asia and Emerging Market Equity Strategy, has noted, earnings for the EM market have been surprisingly weak over the long run and are still at levels similar to 2010. Growth so far has been elusive. Uncertainty around that long term earnings power is one of several reasons that it may be too early to say that EM will be a multiyear outperformer. But for the time being, we think those longer term concerns will be secondary to near-term support and continue to expect cross-asset outperformance from EM assets this year. Thanks for listening. Subscribe to Thoughts on the market on Apple Podcasts, or wherever you listen, and leave us a review. We'd love to hear from you.

As Asia and Emerging Markets move from a year of major adjustment in 2022 towards a less daunting 2023, investors may want to change their approach for the beginning of a new bull market.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, in this episode on our 2023 outlook, I'll focus on why we recently turned more bullish on our coverage. It's Thursday, 1st of December at 8 a.m. in Singapore. 2022 was a year of major adjustment, with accelerating geopolitical shifts towards a multipolar world, alongside macro volatility caused by a surge in developed markets inflation, and the sharpest Fed tightening cycle since the Paul Volcker era 40 years ago. This took the U.S. dollar back to early 1980s peaks in real terms, and global equities fell sharply, with most markets down by double digit percentages. North Asian markets performed worse as a slowdown in tech spending, and persistently weak growth in China, weighed on market sentiment. But structural improvement in macro stability and governance frameworks was rewarded for Japan equities, as well as markets in Brazil, India and Indonesia. Our 2023 global macro outlook paints a much less daunting picture for equity markets, despite a slower overall GDP growth profile globally than in 2022. Current market concerns are anchored on inflation and that central banks will keep hiking until the cycle ends with a deep recession, a financial accident en route, or perhaps worse - that they leave the job half done. But, and crucially, our economists forecast that U.S. core PCE inflation will fall to 2.5% annualized in the second half of next year. Alongside slowing labor market indicators, our team sees January as the last Fed hike, with rates cuts coming as soon as the fourth quarter of 2023, down to a rate of 2.375% at the end of 2024. Meanwhile, inflation pressures in Asia remain more subdued than elsewhere. This top down outlook of growth, inflation and interest rates all declining in the U.S. and continued reasonable growth and inflation patterns in Asia should lead to a weaker trend in the U.S. dollar, which tends to be associated with better performance from Asia and emerging market equities.Meanwhile, for the China economy, we think a gradual easing of COVID restrictions and credit constraints on the property sector deliver a cyclical recovery, which drives growth reacceleration from 3.2% in 2022 to 5.0% in 2023. Consumer discretionary spending, which is well represented in the offshore China equity markets, should show the greatest upturn year on year as 2023 progresses. Crucially, this means that we expect corporate return on equity in China, which has declined in both absolute and relative terms in recent years, to pick up on a sustained basis from the current depressed level of 9.5%. We also think that end market weakness in semiconductors and technology spending, consequent upon the reversal of the COVID era boom, should gradually abate. Our technology and hardware teams expect PC and server end markets to trough in the fourth quarter of this year, whereas smartphone has already bottomed in the third quarter. They recommend looking beyond the near-term weakness to recognize upside risks, with valuations for the sector now at prior market troughs and the current pain and fundamentals priced in by recent earnings estimates downgrades in our view. We therefore upgraded Korea and Taiwan and the overall Asia technology sector in early October and expect these parts of our coverage to lead the new bull market into 2023. Finally, given greater GDP growth resilience and less sector exposure to global downturns, Southeast Asian markets such as Singapore, Malaysia, Indonesia and Thailand, collectively ASEAN, tend to outperform emerging markets in Asia during bear markets, but underperform in bull markets given their low beta nature. Having seen a sharp spike in ASEAN versus Asia, relative performance in the prior bear market, which we think is now ending, our view is that the trend should reverse from here. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

Asia and EM equities are on the verge of the longest bear market in their history, so what is the likelihood that a sharp fall in prices follows soon after?----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, today I'll be discussing the ongoing bear market in Asia and Emerging Market equities. It's Thursday, September the 29th at 8 a.m. in Singapore. We have repeatedly emphasized that patience may be rewarded during what will likely, by the end of this month, become the longest bear market in the history of Asia and Emerging Market equities. Indeed, we argued that the August Jackson Hole speech by Fed Chair Powell, and the mid-September upside surprise in U.S. CPI inflation likely accelerated a downward move towards our bear case targets near term. And in recent weeks, the MSCI Emerging Markets Index has indeed given back almost all of the gains it had recorded from the COVID recession lows. To our mind, this raises the likelihood that a classic capitulation trough, a sudden sharp fall in prices and high trading volumes, could be forming in a matter of weeks. Now, all cycles are not made alike, and this one is unusual in a number of key regards. Most notably, the dislocations in the supply side of the global economy caused by COVID and geopolitics. Moreover, China is not easing policy to the same extent as helped generate troughs in late 2008 and early 2016. Thus, caution is warranted in drawing too firm a set of conclusions from relationships that have held in the past. That said, by the end of this month, the current bear market will likely become the longest in the history of the asset class, overtaking in days duration that triggered by the dot com bust in the early 2000's. And after a more than 35% drawdown, the MSCI Emerging Markets Index is now trading close to prior trough valuations at only 10x price to consensus forward earnings. Our experience covering all previous bear markets back to 1997/1998 suggests to us ten sets of indicators to monitor. We've recently undertaken an exercise to score each indicator from 1, which equates to a trough indicator not enforced at all to 5, which indicates a compelling trough indicator already in place. Currently, the sum of the scores across the factors is 32 out of a maximum of 50, which we view as suggesting that a trough is approaching but not yet fully conclusive at this stage. In our view, the U.S. dollar, which continues to rise, including after the most recent FOMC meeting, gives the least sign of an impending trough in EM equities. Whilst the underperformance of the Korean equity market and the semiconductor sector, the recent sharp fall in oil price and the fall in the oil price relative to the gold price give the strongest signs. In this regard, we would note that within our coverage we recently downgraded the energy sector to neutral, upgrading defensive sectors, including telecoms and utilities. We intend to update the evolution of these indicators as appropriate as we attempt to help clients move through the trough of this unusually long Asia and Emerging Markets equity bear market. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

As Asia and EM equities continue to experience what may end up being the longest bear market in the history of the asset class, looking to past bear markets may give investors some insight into when to come off the sidelines.-----Transcript-----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, today I'll be discussing whether we're nearing the end of the current bear market in Asia and emerging market equities. It's Wednesday, August the 24th, at 8 a.m. in Singapore. The ongoing bear market in Asia and EM equities is the 11th which I've covered as a strategist. And in this episode I want to talk about some lessons I've learned from those prior experiences, and indeed how close we may be to the end of this current bear market. A first key point to make is that this is already the second longest in duration of the 11 bear markets I've covered. Only that which began with the puncturing of the dot com bubble by a Fed hike cycle in February 2000 was longer. This is already a major bear market by historical standards. My first experience of bear markets was one of the most famous, that which took place from July 1997 to September 1998 and became known as the Asian Financial Crisis. That lasted for 518 days, with a peak to trough decline of 59%. And as with so many others, the trigger was a tightening of U.S. monetary policy at the end of 1996 and a stronger U.S. dollar. That bear market ended only when the U.S. Federal Reserve did three interest rate cuts in quick succession at the end of 1998 in response to the long term capital management and Russia defaults. Indeed, a change in U.S. monetary policy and/or a peak in the U.S. dollar have tended to be crucial in marking the troughs in Asia and EM equity bear markets. And that includes the two bear markets prior to the current one, which ended in March 2020 and October 2018. However, changes in Chinese monetary policy and China's growth cycles, starting with the bear market ending in October 2008, have been of increasing importance in recent cycles. Indeed, easier policy in China in late 2008 preceded a turn in U.S. monetary policy and helped Asia and EM equities lead the recovery in global markets after the global financial crisis. Although China has been easing policy for almost a year thus far, the degree of easing as measured by M2 growth or overall lending growth is smaller than in prior cycles. And at least in part, that's because China is attempting to pull off the difficult feat of restructuring its vast and highly leveraged property sector, whilst also pursuing a strategy of COVID containment involving closed loop production and episodic consumer lockdowns. Those key differences are amongst a number of factors which have led us to recommend staying on the sidelines this year, both in our overall coverage in Asia and emerging markets, but also with respect to China. We have preferred Japan, and parts of ASEAN, the Middle East and Latin America. Finally, as we look ahead I would also note that one feature of being later on in a bear market is a sudden fall in commodity prices. And certainly from mid-June there have been quite material declines in copper, iron ore and more recently, the oil price. Meanwhile, classic defensive sectors are outperforming. And that sort of late cycle behavior within the index itself raises the question of whether by year end Asia and EM equities could once again transition to offering an interesting early cycle cyclical play. That more positive scenario for next year would depend on global and U.S. headline inflation starting to fall back, whether we would see a peak in the U.S. dollar and Fed rate hike pricing.For the time being, though, as the clock ticks down to the current bear market becoming the longest in the history of the asset class, we still think patience will be rewarded a while longer. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and recommend Thoughts on the Market to a friend or colleague today.

As the risks to international economic growth increase, global investors may find some good news in the Japanese equities market. -----Transcript-----Welcome to Thoughts on the Market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Markets Equity Strategist. Along with my colleagues, bringing you a variety of perspectives, today I'll be reflecting on a recent visit to Japan. It's Thursday, June the 30th, at 1 p.m. in London. I spent two weeks in Tokyo meeting with a wide range of market participants and others. This trip came together as Japan opened up to business visitors and small groups of tourists, after a lengthy period of COVID related travel restrictions. Japan equities - currency hedged for the U.S. dollar based investor - are our top pick in global equities and have been doing well this year relative to other markets. My first impression was how cheap prices in Japan now are at the current exchange rate of ¥135 to the U.S. dollar. For example, a simple metro journey in the inner core of Tokyo is priced at ¥140, so almost exactly $1 USD currently. It's possible to get a delicious lunchtime meal of teriyaki salmon, rice, pickles, miso soup and a soft drink in one of the numerous small cafes under the giant urban skyscrapers of the Central District of Marinucci for ¥1,000 or even lower. So that's about $6 to $7 USD currently. We feel this competitive exchange rate bodes well for the major Japanese industrial, technology and pharmaceutical firms, which dominate the Japan equity market as they compete globally. Indeed, the currency at these levels is one of the reasons that earnings revisions estimates, by bottom up analysts covering these companies, continue to move higher. Unlike the overall situation in global equities currently. In meetings, I was often asked whether we shared some of the concerns which have been voiced by some commentators on the Bank of Japan's monetary policy stance. The Monetary Policy Committee meeting for June was held during my trip, and the Bank of Japan kept its short term policy rate at -0.1% and also reiterated its pledge to guide the ten year government bond yield at +/- 25 basis points around a target of zero. Clearly, this monetary policy is divergent with trends elsewhere in the world currently and in particularly with the U.S. And this divergence is a key reason why the yen has been weakening this year. We at Morgan Stanley feel strongly that this approach is the right one for Japan, for one key reason. Unlike the U.S., UK or other advanced economies, Japan's inflation rate remains in line with policy goals. Headline CPI inflation is running at just 2.5% year on year, while CPI ex food and energy is 0.8%. Japan does not have a breakout to the upside in wage inflation either. We also think BOJ Governor Kuroda-san was correct in identifying downside risks to international economic growth as a risk factor for Japan's own GDP growth going forward, which at the moment we think is likely to track at around 2% this year. During our trip, we also spent time with investors discussing Japan Prime Minister Kishida-san's modifications to the policies of his two predecessors, in particular around a more redistributive approach to fiscal policy and digitalization of the public sector. The trend to greater corporate engagement with minority investors and activist investors was also debated. Japan is now the second largest market globally after the US for activist investor campaigns to promote corporate restructuring, thereby unlocking shareholder value. For us. Ultimately, the proof of the pudding, and how the Japan story all comes together, is the trend in corporate return on equity for listed equities. This has risen from less than 5% on average in the 20 years prior to Abe-san's premiership to above 10% currently. And it's now converged with two key North Asian peers; China and Korea. With Japan equities trading at the low end of the valuation range for the last 10 years, below 12 x forward price to earnings multiple, we think it's a market which deserves more attention from global investors. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

While there continues to be turbulence in many sectors, such as energy and food, some Asia and Emerging Markets may fare better than others through the second half of an already hectic 2022.-----Transcript-----Welcome to Thoughts on the Market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Markets Equity Strategist. Along with my colleagues bringing you a variety of perspectives, today I'll be talking about our mid-year outlook for Asia and Emerging Markets. It's Tuesday, May the 31st at 8 p.m. in Hong Kong. In our mid-year outlook, our advice was to stick with the markets and sectors which have performed well already this year. These are in the main plays on high energy, materials and food prices. In our coverage, this means commodity exporters including Australia, Indonesia and Saudi Arabia, which we have been overweight for some time. We also added another commodity exporter, Brazil, to this overweight group and reiterated our overweight on energy and materials. Despite outperformance, we continue to encounter skepticism that these markets and sectors can continue to perform. And this is mainly due to concerns over global growth, and in particular growth in China. Certainly, it's true that energy and materials tend to perform well late on in the cycle, whereas I.T hardware, semiconductors and consumer discretionary tend to do well coming out of recession. And it's also true that the Chinese economy is weak right now, with data showing a considerable slowdown in April and May. And that is a key reason why we remain cautious on China equities themselves. But we think the combination of underinvestment in the prior cycle in supply and the Russia-Ukraine conflict keep the commodity markets tight for the foreseeable future. The pattern of earnings revisions confirms our thesis. Analysts are upgrading numbers for stocks in Australia, Brazil, Indonesia and Saudi Arabia, in some cases at an accelerating pace. Whilst they're downgrading for China, Korea and Taiwan, which are manufacturing exporting and commodity importing markets, Japan is slightly different, with balanced earnings revisions as corporate margins are helped by the recent trend to a weaker yen, amongst other factors. Hence, thus far, for some key emerging markets, notably Brazil and Indonesia, their commodity producing and exporting characteristics are offsetting, both from a currency and equity market perspective, the traditionally negative impact on growth from a stronger U.S. dollar and monetary policy tightening by the U.S. Federal Reserve. In time, this pronounced pattern of earnings dispersion may reverse and we are on the lookout for a trend reversal. This could be driven by factors like a change in COVID management approach in China or cessation of the conflict in Ukraine. For the time being though, we recommend keeping things simple in turbulent times. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

I met Jonathan Garner at an event in Saudi Arabia on a panel discussing digital wellbeing. It became clear to me that Jonathan has dedicated a massive amount of time to figuring out how we can not only combat our often unhealthy reliance on technology but actually turn it into an opportunity for serious self-development. We discuss exactly that in this week's episode.In 2016, Jonathan was working as a digital educator and noticing that while tech is really powerful, bad digital habits often end up blocking our human potential by reducing our happiness, productivity, effectiveness and diversity. In response, he founded Mind over Tech in 2018, a company that helps develop habits and mindsets to unlock the human potential of hybrid teams. They recently published the  Digital Habit Lab—a physical toolkit of 50 experiments to help anyone take back control of their tech.Listen as we discuss:Does technology control us or do we control it?The technologies that changed history and what was gained and lost from them.Why I'm proud to have worked at early Google.How Jonathan's company Mind Over Tech was born.Why reliance on technology is actually a starting place for self-development.Swiping and liking - the dangerous habits.A few powerful experiments from Jonathan's Digital Habit Lab.Embrace boredom!Instagram: @mo_gawdatFacebook: @mo.gawdat.officialTwitter: @mgawdatLinkedIn: /in/mogawdatYouTube: @mogawdatofficialWebsite: mogawdat.comConnect with Jonathan Garner on Twitter @mindovertech and get the deck over at  mindovertech.comDon't forget to subscribe to Slo Mo for new episodes every Sunday. Only with your help can we reach One Billion Happy #onebillionhappy.

Forecasts for China and other Emerging Markets have continued on a downtrend, extending last year's underperformance, meaning investors might want to look into regions with a more favorable outlook.Important note regarding economic sanctions. This research references country/ies which are generally the subject of selective sanctions programs administered or enforced by the U.S. Department of the Treasury's Office of Foreign Assets Control (“OFAC”), the European Union and/or by other countries and multi-national bodies. Users of this report are solely responsible for ensuring that their investment activities in relation to any sanctioned country/ies are carried out in compliance with applicable sanctions.-----Transcript-----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Markets Equity Strategist for Morgan Stanley Research. Along with my colleagues bringing you a variety of perspectives, today I'll be talking about the key reasons why we recently reiterated our cautious stance on overall emerging market equities and also China equities. It's Friday, April 22nd at 8:00 p.m. in Hong Kong. Now, emerging market equities are underperforming again this year, and that's extending last year's underperformance versus developed market equities. And so indeed are China equities, the largest component of the Emerging Market Equities Index. This is confounding some of the optimism felt by some late last year that a China easing cycle could play its normal role in delivering a trend reversal. We have retained our cautious stance for a number of reasons. Firstly, the more aggressive stance from the US Federal Reserve, signaling a rapid move higher in US rates, is leading to a stronger US dollar. This drives up the cost of capital in emerging markets and has a directly negative impact on earnings for the Emerging Markets Index, where around 80% of companies by market capitalization derive their earnings domestically. Secondly, China's own easing cycle is more gradual than prior cycles, and last week's decision not to cut interest rates underscores this point. This decision is driven by the Chinese authorities desire not to start another leverage driven property cycle. Meanwhile, China remains firmly committed to tackling COVID outbreaks through a lockdown strategy, which is also weakening the growth outlook. Our economists have cut the GDP growth forecast for China several times this year as a result. Beyond these two factors, there are also other issues at play undermining the case for emerging market equities. Most notably, the strong recovery in services spending in the advanced economies in recent quarters is leading to a weaker environment for earnings growth in some of the other major emerging market index constituents, such as Korea and Taiwan. They have benefited from the surge in work from home spending on goods during the earlier phases of the pandemic. Meanwhile, the geopolitical risks of investing in emerging markets more generally have been highlighted by the Russia Ukraine conflict and Russia's removal from the MSCI Emerging Markets Index. So what do we prefer? We continue to like commodity producers such as Australia and Brazil, which are benefiting from high agricultural, energy and metals prices. We also favor Japan, which, unlike emerging markets, has more than half of the index deriving its earnings overseas and therefore benefits from a weaker yen. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

As global markets face a rise in commodity prices due to geopolitical conflict, investors in Asia and EM equities will want to keep an eye on the divergence between commodity exporters and importers.Important note regarding economic sanctions. This research references country/ies which are generally the subject of comprehensive or selective sanctions programs administered or enforced by the U.S. Department of the Treasury's Office of Foreign Assets Control (“OFAC”), the European Union and/or by other countries and multi-national bodies. Any references in this report to entities, debt or equity instruments, projects or persons that may be covered by such sanctions are strictly informational, and should not be read as recommending or advising as to any investment activities in relation to such entities, instruments or projects. Users of this report are solely responsible for ensuring that their investment activities in relation to any sanctioned country/ies are carried out in compliance with applicable sanctions.-----Transcript-----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist for Morgan Stanley Research. Along with my colleagues bringing you a variety of perspectives, I'll be talking about geopolitical risk, commodity exposure, and how they affect our views on Asia and EM Equities. It's Tuesday, March the 15th at 8:00 p.m. in Hong Kong. The Russia Ukraine conflict is having a profound impact on the investment world in multiple dimensions. In this episode we focus on just two, commodity prices and geopolitical alignment, and what they mean for investors in Asia and emerging market equities. The major sanctions imposed by the U.S., U.K., European Union and their allies are focused not only on isolating Russia financially but depriving it, in some instances overnight and in others more gradually, of the ability to export its commodities. And Russia is a major producer of oil, natural gas, food and precious metals and rare minerals. Ukraine is also a major food exporter. In our coverage there's a sharp divergence between economies which are major commodity importers, and are therefore suffering a negative terms of trade shock as commodity prices rise, and those which are exporters and hence benefit. Major importers include Korea, Taiwan, China and India, all with more than a 5% of GDP commodity trade deficit. Meanwhile, Australia, Mexico, Brazil, Saudi Arabia, UAE and South Africa are all significant commodity exporters and stand to benefit. Australia's overall commodity trade surplus is the largest at 12% of GDP, and that is before the recent gains in price for almost everything which Australia produces and exports. Meanwhile, on the geopolitical risk front, we've been monitoring the pattern of voting on Russia's actions at the United Nations, where there have been both UN Security Council and General Assembly votes. Although none of the countries we cover actually voted with Russia on either occasion, two major countries, China and India, did abstain twice. South Africa abstained at the General Assembly. The UAE abstained in the Security Council, but then voted with the US and Europe in the General Assembly vote. This pattern of voting, in our mind, may have an impact in raising the equity risk premium, i.e. lowering the valuation, for China and to a lesser extent India in the current environment. All taken together, we are shifting exposure further towards commodity exporting markets and in particular those such as Australia, which are also geopolitically aligned with the major sources of global investor flows. We lowered our bear-case scenario values for China further recently and are turning incrementally more cautious on India. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

As investors face the multitude of risks ahead, one may need to think like the Tiger and use the rotation towards value stocks, and away from growth, to leap over higher hurdle rates this year. ----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist for Morgan Stanley Research. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about Asia and emerging market equities in the year ahead. It's Monday, February the 14th at 8:30 p.m. in Hong Kong.Welcome to the Year of the Tiger from the Morgan Stanley team in Asia. Ferocious, brave, and intelligent, the tiger inspires us to navigate the multitude of risks which confront investors today. For us in Asia, we're at first sight on the sidelines of the action as expectations build for a sea-change this year in monetary policy in the US and Europe.Indeed, we have a degree of sympathy with the argument that the different phase of the monetary and fiscal cycle in China, in essence a moderate easing, is a key reason to be more constructive on Asian markets performance this year in both absolute and relative terms.However, divergent policy cycles are only part of the story. North Asia has already benefited substantially from the major shift towards good spending and away from services, which has been such a unique feature of the COVID driven recession and recovery. Now, as that starts to reverse, given the reopening trend in the US and Europe, we may see earnings growth in markets like Korea and Taiwan slow. Moreover, significant challenges in relation to COVID management still beset the region, most notably in Hong Kong, which is experiencing its largest surge in cases since the pandemic began.A key call that Morgan Stanley's equity strategy team made three months ago, in our year ahead outlook, was that investors on a worldwide basis should rotate away from growth stocks. That is, stocks with high expected earnings growth and high valuations towards value stocks. That is those with lower valuations, more dividend yield support, and lower anticipated earnings growth, not least due to the fact that many businesses in the value style category tend to be more established than growth stocks.This rotation has indeed taken place, as evidenced not just by Nasdaq's underperformance in the US, but also the underperformance of growth stocks in Asia and emerging markets. This has been reflected in indices like Kosdaq in Korea or the TSE Mothers Index in Japan. In fact, in Japan banks and insurers, stocks which investors have not focused on for a long time, are leading in performance in 2022. Whilst in China, bank stocks have been outperforming internet stocks for some time now.For those of us who worked through the 1999 to 2002 cycle in global equities, things seem very familiar. History rhymes rather than repeats, but the catalyst for growth stock underperformance then, as now, was a sudden repricing of interest rate hike expectations with a shift higher in nominal and real interest rates. That higher hurdle rate depresses valuations for equities generally, but particularly for higher multiple growth stocks, further motivation for the rotation towards value stocks.So. investors may need to start thinking like the tiger in order to leap over that hurdle and land safely on the other side.Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

What are these “cards” we keep talking about on the podcast? To celebrate launching the cards on Kickstarter, join host Menka Sanghvi in a conversation with the founder of Mind over Tech as they reflect on their personal experience of testing out six digital habit lab cards that they've found really useful. And, find out how you can get your own deck now on Kickstarter: https://www.kickstarter.com/projects/j0nathan/digital-habit-lab?ref=9rnklh

Sunday morning worship lesson by Jonathan Garner

Despite last year's strong showing for European equities, will the recent spread of the Omicron variant derail our positive outlook for the region in 2022?----- Transcript -----Welcome to Thoughts on the Market. I'm Graham Secker, Head of Morgan Stanley's European Equity Strategy team. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the recent rise in Omicron cases and whether this could derail our constructive view on European equities for 2022. It's Thursday, January the 6th at 2:00 p.m. in London. Before touching on Omicron and the case for European stocks in 2022, I want to start by looking back at last year, which ended up being a very good one for the region. True European equities did lag US stocks again in 2021, however, this is hard to avoid when global markets are led higher by technology shares given Europe has fewer large cap companies in this space. More impressive was Europe's performance against other regions such as Japan, Asia and emerging markets. In fact, when we measure the performance of MSCI Europe against the MSCI All Countries World Index, excluding U.S. stocks, then we find that Europe enjoyed its best year of outperformance since 1998 which, to provide some context, was the year before the euro came into existence. As ever, past performance is not necessarily a good guide to future returns. However, in this instance, we do expect another year of positive returns for European stocks in 2022, with 7% upside to our index target in price terms, which rises to 10% once dividends are included. This is considerably better than our Chief US Equity Strategist, Mike Wilson, expects for the S&P, while Jonathan Garner, our Chief Asian Equity Strategist, also remains cautious on Asian and emerging markets at this time. While we think the underlying assumptions behind that positive view on European stocks are actually quite conservative - we model 10% EPS growth and a modest PE de-rating - equity investors are likely to have to navigate greater volatility going forward, given scope for higher uncertainty around COVID, inflation, and the impact of tighter monetary policy on asset markets. The first of these factors was arguably the most important for markets through November and December, however, recent evidence that emerged very late in the year - that Omicron is indeed considerably less severe than prior mutations - has boosted risk appetite across the region, helping push bond yields and equity prices higher. From a more fundamental perspective, we are also encouraged that the sharp rise in COVID cases across Europe over the last couple of months does not appear to be having a significant impact on the economy. Yes, we did see quite a sharp drop in business surveys in Germany through December, however, this doesn't appear to be replicated elsewhere with the PMI services data in France and consumer confidence data in Italy staying strong for now. Going forward, we expect the driver of volatility and uncertainty to shift from COVID to central banks and the impact of tighter monetary policy on asset markets. While this issue will be relevant across all global markets, Europe should be less negatively impacted than elsewhere given the European Central Bank is unlikely to raise interest rates through 2022. In addition, the European equity market's greater exposure to the more value-oriented sectors such as commodities and financials, should make it a relative beneficiary of rising bond yields, especially if - as our Macro Strategy team forecast - this is accompanied by rising real yields (which should weigh most on the more expensive stocks in the US) or a stronger US dollar (which is more of a headwind for emerging markets). Consistent with this outlook, we maintain a strong bias for value over growth here in Europe, with a particular focus on banks, commodity stocks and auto manufacturers. While all three of these sectors outperformed last year, we think they are still cheap and hence offer more upside from here. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

As the Omicron variant spreads across Asia, renewed lockdowns and other earnings outlook disruptions have investors on alert, reinforcing our approach of cautious patience in the region.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Market Equity Strategist for Morgan Stanley Research. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the impact of Omicron on China and Emerging Market Equities. It's Tuesday, January the 4th at 7:30 a.m. in Hong Kong. As 2022 begins, our approach to Asia and EM equities remains one of cautious patience. Although these markets underperformed their peers in the U.S. and Europe last year, simple arguments of performance mean reversion in 2022 are not strong enough to warrant anything more aggressive at this juncture. We hear a lot these days about a turn in the Chinese policy cycle as a catalyst. And it's fair to say that historically one would have been more optimistic at this juncture of the monetary and fiscal cycle for the outlook for domestic demand in China. This demand is crucial both for China's own growth outlook to stabilize, as well as to give a boost to most other markets in Asia and EM. But this is not a normal cycle. China's ‘zero COVID' approach must now face off against Omicron. As this episode is being recorded, Xian - a major Chinese city with a population of over 13 million - is in its 12th day of a lockdown, which is now more severe in terms of restrictions on normal daily life than any seen in China since the original lockdown of Wuhan at the start of the pandemic. Two global companies with major semiconductor plants in the city have recently warned of production problems. And though there's no formal national policy to curtail celebration of Chinese New Year at the end of this month, domestic media is already beginning to broadcast a message of staying at home and avoiding long distance travel. In China, as in EM, we're continuing to track earnings estimates that are declining, which undermines the case for valuations - now roughly in line with long run averages - being sufficiently attractive to reengage. The situation is slightly better in Japan, where estimates are tracking sideways and individual markets - notably India and parts of Asean and Eastern Europe, Mid East and Africa - have been doing better than the EM overall. However, disruption caused by Omicron could change individual economic and hence earnings outlooks over the short to medium term. For example, India's most recent COVID case count was up 35% day-on-day, with Omicron now present in 23 of 28 states. Maharashtra, Delhi and Tamil Nadu have reimposed restrictions on visits to public parks, beaches and other public spaces. Indeed, most of the countries we cover that had moved to a "living with COVID" approach are now having to reverse course. Take South Korea, which in mid-December, as ICU usage rose significantly, reimposed early closing restrictions on nightlife and a rule limiting public gatherings to no more than four fully vaccinated persons. Finally, our weekly track of flows to dedicated Asia and EM equity funds is now showing steady and persistent redemptions, as some of the very large inflows from this time a year ago start to reverse course. Those flows were driven by the notion that a strong, synchronized upswing was underway globally, which it was argued would lead to outperformance by Asia and EM, whose economies generally perform strongly in a global economic upswing. We argued at the time that 2021 would not be like 2006/07 and 2016/17 when that narrative did hold true. As 2022 begins, the global and local economic outlook is clearly weakening again, and hence our mantra of continued cautious patience. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Global moves in elections, COVID restrictions and energy prices are having ripple effects across markets. How should investors think about these dynamics for Asia and EM equities?----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, chief Asia and Emerging Markets Equity Strategist for Morgan Stanley Research. Along with my colleagues, bringing you their perspectives, today I'll be talking about our latest view on Asia and EM equities. It's Friday, November the 5th at 2pm in London.Overall, in our coverage, we continue to prefer Japan to Non-Japan Asia and Emerging Markets. Japan has outperformed Emerging Markets by 500 basis points year to date but remains cheaper to its own recent valuation history than Emerging Markets and with stronger upward earnings revisions. New Liberal Democratic Party leader Kishida-san has recently fought and won a snap election in the lower house of the Japanese parliament. The governing Center-Right coalition, which he now leads, did considerably better than polling had suggested prior to the election outcome. Although there may be some changes in policy emphasis compared with the Abe and Suga premierships, the broad contours of market-friendly macro and micro policy in Japan are likely to continue.Elsewhere within Emerging Markets, we're most constructive on Eastern Europe, Middle East and Africa and in particular Russia, Saudi Arabia and UAE, which are positively leveraged to rising energy prices. We're also warming up to ASEAN, having upgraded Indonesia to overweight alongside our existing overweight on Singapore. ASEAN economies are finally beginning to reopen post-COVID, which is stimulating domestic consumption.However, we have recommended taking profits on Indian equities after a year of exceptionally strong performance. We remain structurally bullish on a cyclical recovery in earnings growth in India, but with forward price earnings valuations now very high to history and peers, and with rising energy prices a headwind for India, we think it's time to move to the sidelines. Within Latin America, we've also established a clear preference for Chile versus Brazil on relative economic momentum and export price dynamics.Finally, we remain underweight Taiwan and equal weight China. For Taiwan, our contrarian negative view relates to our expectation of a semiconductor downcycle in 2022 and a slowing retail investor boom. Meanwhile, China equities continue to face numerous headwinds, including Delta variant COVID outbreaks, property developer deleveraging and the medium to long term impact on private sector growth stocks from the recent regulatory reset. Although valuations have improved in pockets, we expect further earnings downgrades for China and await a clearer pickup in growth and liquidity before turning more constructive.Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

With incoming global growth data missing consensus expectations, emerging markets equity earnings revisions could fall back into negative territory for the first time since May 2020.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Garner, Chief Asia and Emerging Markets Equity Strategist for Morgan Stanley Research. Along with my colleagues, bringing you their perspectives, today I'll be talking about a key recent development, which is the deterioration in the global growth outlook and what it means for Asia and EM equities. It's the 29th of September at 7:30 a.m. in Hong Kong. Incoming global growth data is starting to miss expectations by a wide margin. This appears to be mainly due to the impact of Delta-variant covid on consumer confidence, but also continued supply chain bottlenecks on the corporate sector. The Global Economic Surprise Index, i.e., the extent to which top-down global macro data beats or misses economists' expectations, has fallen in a straight line from a level of +90 in mid-June to -24 currently. It was last this low at the end of March 2020, at the beginning of the global impact of the pandemic, and before that in the second quarter of 2018, at the start of US-China tariff hikes and the imposition of non-tariff barriers to trade. So in short, there's been a sudden downward lurch relative to expectations for global macro in relation to the narrative from consensus of a continued strong recovery, broadening out by geography, and entering a virtuous circle of rising consumption and investment. Global equity markets have wobbled recently but are still trading close to their all-time highs set in early September. We think the key to understanding what happens next is to understand the relationship between Economic Surprise data and earnings revisions. We've found that changes in the Global Economic Surprise index tend to have a good leading relationship for how bottom-up analyst earnings revisions evolve three months later. And that, in turn drives market performance. And this matters because the covid recession and recovery have already witnessed exceptionally sharp movements, both in economic data - relative to consensus - and earnings estimate revisions. Indeed, they've been more extreme even than the volatility that we saw at the time of the Global Financial Crisis. So, at this level of -24 on economic surprise, our analysis suggests 12-month forward EPS expectations will likely decline by around 150bps over the next three months. That may not sound like much, but it compares with a current positive QoQ upward revision of 530bps and a peak QoQ revision of 1100bps in May of this year. Within our coverage, some markets have already gone through the transition adjustment to slower expected earnings revisions - most notably China, where we remain cautious. Our analysis finds that strong performance and strong revisions are positively correlated and vice versa for weak performance and poor revisions. Japan, Russia and South Africa are the standouts recently for positive revisions, and they may show some resilience to the deteriorating global situation. China, Indonesia, Malaysia and Thailand have had the worst revisions and generally poor performance; but China has also been underperforming due to investors assigning a lower valuation to the market due to this year's regulatory reset. Overall, we continue to prefer Japan to EM and China. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Taiwan equities have been a standout among equities in 2021, but factors such as softening tech spend and slowing retail trading activity suggest challenges ahead.

On this episode, we examine how China's regulatory reset on fintech, big tech, cryptocurrency and carbon emissions could affect China equities and business models.

As the year began, there was a high degree of optimism that 2021 could be a great year for Asia & EM equities. But instead, Asian equities have lagged the U.S. and Europe. So what went wrong?

In today's episode, we feature Jonathan Garner, the Founder of Mind Over Tech - a wellbeing & productivity company helping people transform from distracted end-users to intentional humans who make technology work for them. In this episode, Jonathan talks to us about the importance of intentional technology use as a route to psychological wellbeing and enhanced productivity, the most impactful people in the intentional technology space at the moment, and the steps you can take right now to create a better relationship with your digitised life.

Jonathan Garner discusses the evolution of work and how companies now need to invest in their teams in new ways. In a hybrid workplace how do we recreate water-cooler moments? Our guest this week is clear - zoom quizzes are not the answer. Instead, how about investing in a Culture of You. In this episode, we welcome Jonathan Garner, founder or Mind Over Tech. Through live sessions and scalable online programmes Mind over Tech helps people embrace technology with intention. Their clients include Vodafone, Google, KPMG, The Cabinet Office, Natwest Group, Just Eat, and they are increasingly starting to bring their offerings to individuals as well. In this episode we discuss: the reality of burnout in a pandemic the challenges of a new hybrid working environment why companies need to invest in the culture of individuals. Mind over Tech (https://www.mindovertech.com/) Mot Newsletter (https://mot.fyi/newsletter) Digital Habits Lab (https://www.mindovertech.com/digital-habits) Host and Producer: Georgie Powell Music: Toccare

Sunday Evening Worship - Lesson by Jonathan Garner

On today's episode, To understand the impact of the Coronavirus on humanity, economics and markets, Chief Asia and Emerging Markets Equity Strategist Jonathan Garner draws parallels with the 2002 SARS outbreak.

Jonathan Garner, Chief Asia and Emerging Markets equity strategist kicks off his premiere episode with what is likely the most interesting—and overlooked—turnaround story in equity markets.

In today’s episode, we feature Jonathan Garner, the Founder of Mind Over Tech - a wellbeing & productivity company helping people transform from distracted end-users to intentional humans who make technology work for them. In this episode, Jonathan talks to us about the importance of intentional technology use as a route to psychological wellbeing and enhanced productivity, the most impactful people in the intentional technology space at the moment, and the steps you can take right now to create a better relationship with your digitised life.

Part two of an interview with Michelle Bright and Jonathan Garner from the Lady Bird Johnson Wildflower Center centering on projects where water was a major concern and about the benefits of green roofs.

Michael Covel received an email from Jonathan Garner about a blog post from Derek Hernquist titled “I Have No Idea What Tesla Is Worth, Do You?”. It linked to a CNBC interview with an analyst named Brian Shannon. Covel plays the CNBC clip and gives commentary at specific points. Covel shares the technical analysis viewpoint with Shannon, but disagrees when it comes to price targets. Covel also points out some terms that aren’t part of the vocabulary of a trend following trader. A pure, predictive technical analyst could go that direction, but that’s not trend following. Covel isn’t trying to slam Shannon, who is trying to fight the good fight from a price action perspective. Rather, Covel focuses on CNBC’s coverage and one particular talking head who has no idea about technical analysis. Covel points out that even if you’re a purely fundamental trader, you have to know what trend following is, what it does, and how it behaves. Covel focuses on price action and momentum, not Tesla’s latest announcement. Shannon concludes by talking about risk management, which Covel then discusses. Covel ruminates on why trend following and technical analysis are so confused, and talks about the difference between predictive and reactive technical analysis. Continuing on with another example, Covel tells a story about a young man he met who invested in $10,000 worth of Facebook stock, and why it’s important to have an exit plan. Covel was forwarded the young man’s blog post, which stated the decision to invest in Facebook was based off a wealthy friend’s advice. If you’re going to follow advice, make sure it isn’t made up out of thin air. If you’re going to follow a thought process about how money is made, you have to scientifically dig in and look at the process. If not, it’s just gambling. To close out, Covel talks about a piece he re-read from Malcolm Gladwell about how Nassim Taleb first met Victor Niederhoffer. Want a free trend following DVD? Go to trendfollowing.com/win.